| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 6, 2010Milestone Shows Progress on Indication-Specific Trials for Treating Peripheral Arterial Disease
MINNEAPOLIS, Aug 06, 2010 (BUSINESS WIRE) -- With an expanded focus on addressing peripheral arterial disease (PAD), Medtronic, Inc. (NYSE: MDT), today announced that it has completed enrollment...
-
Aug 5, 2010Minimally Invasive Procedure May Stabilize Bleeding and Improve Clinical Outcomes
MINNEAPOLIS, Aug 05, 2010 (BUSINESS WIRE) -- Marking a major milestone toward expanding the use and utility of minimally invasive endovascular procedures, Medtronic, Inc. (NYSE: MDT), today...
-
Jul 29, 2010Medtronic Launches Novel Clinical Trial Evaluating Spinal Cord Stimulation Therapy for Heart FailureDefeat-HF Trial Aims to Slow HF Progression with Neurostimulation
MINNEAPOLIS, Jul 29, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the global launch of the Defeat-HF (Determining the Feasibility of Spinal Cord Neuromodulation for the...
-
Jul 27, 2010IMPROVE HFStudy Published in Circulation Demonstrates Improved Adherence to Five of Seven Guideline-Recommended Care Measures
MINNEAPOLIS, Jul 26, 2010 (BUSINESS WIRE) -- Results of the largest U.S. outpatient heart failure clinical study show that implementation of a process improvement program significantly improved...
-
Jul 27, 2010New biologic bone graft product demonstrated superior fusion rates compared to current standard of care for complex fusion procedures of the lower spine in the pivotal clinical trial
MINNEAPOLIS, Jul 27, 2010 (BUSINESS WIRE) -- The U.S. Food and Drug Administration (FDA) Orthopaedic and Rehabilitation Devices Panel today voted 9 for and 4 against (1 abstention) on safety and...